Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

ASNI Calgary 2015
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
Fatigue and Comorbidities in Multiple Sclerosis.
Clarity Extension Study
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Episode 21 with Dr. Paul Matthews discussing imaging in MS
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Influence of infection on exacerbations of multiple sclerosis.
Autoimmune sleep disorders.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Brain and BrainPET 2015
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.

Pages